Apoptosis Activity of Persea declinata (Bl.) Kosterm Bark Methanolic Crude Extract

Persea declinata (Bl.) Kosterm is a member of the
Lauraceae family, widely distributed in Southeast Asia. It is from the
same genus with avocado (Persea americana Mill), which is widely
consumed as food and for medicinal purposes. In the present study,
we examined the anticancer properties of Persea declinata (Bl.)
Kosterm bark methanolic crude extract (PDM). PDM exhibited a
potent antiproliferative effect in MCF-7 human breast cancer cells,
with an IC50 value of 16.68 .g/mL after 48h of treatment. We
observed that PDM caused cell cycle arrest and subsequent apoptosis
in MCF-7 cells, as exhibited by increased population at G0/G1 phase,
higher lactate dehydrogenase (LDH) release, and DNA
fragmentation. Mechanistic studies showed that PDM caused
significant elevation in ROS production, leading to perturbation of
mitochondrial membrane potential, cell permeability, and activation
of caspases-3/7. On the other hand, real-time PCR and Western blot
analysis showed that PDM treatment increased the expression of the
proapoptotic molecule, Bax, but decreased the expression of
prosurvival proteins, Bcl-2 and Bcl-xL, in a dose-dependent manner.
These findings imply that PDM could inhibit proliferation in MCF-7
cells via cell cycle arrest and apoptosis induction, indicating its
potential as a therapeutic agent worthy of further development.





References:
[1] K. H. Lee, “Antineoplastic agents and their analogues from Chinese
traditional medicine,” in HumanMedicinal Agents from Plants, A. D.
Kinghorn andM. Balandrin, Eds., vol. 534 of ACS Symposium Series,
pp. 170–190, American Chemical Society, Washington, DC, USA, 1993.
[2] K.-H. Lee, “Anticancer drug design based on plant-derived natural
products,” Journal of Biomedical Science, vol. 6, no. 4, pp. 236–250,
1999.
[3] H. Ding, Y.-W. Chin, A. D. Kinghorn, and S. M. D’Ambrosio,
“Chemopreventive characteristics of avocado fruit,” Seminars in Cancer
Biology, vol. 17, no. 5, pp. 386–394, 2007.
[4] V. R.Gummadi, S. Rajagopalan, C.Y. Looi et al., “Discovery of 7-
azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild
type and mutant (L1196M) active compounds with unique binding
mode,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 17, pp.
4911–4918, 2013.
[5] C. Y. Looi, M. Imanishi, S. Takaki et al., “Octa-Arginine mediated
delivery of wild-type Lnk protein inhibits TPO-induced M-MOK
megakaryoblastic leukemic cell growth by promoting apoptosis,” PLoS
ONE, vol. 6, no. 8, article e23640, 2011.
[6] C. Y. Looi, B. Moharram, M. Paydar et al., “Induction of apoptosis in
melanoma A375 cells by a chloroform fraction of Centratherum
anthelminticum (L.) seeds involves NF-kappaB, p53 and Bcl-2-
controlled mitochondrial signaling pathways,” BMC Complementary
and Alternative Medicine, vol. 13, article 166, 2013.
[7] R. S. Ahmed, S. G. Suke, V. Seth, A. Chakraborti, A. K. Tripathi, and
B.D. Banerjee, “Protective effects of dietaryginger (Zingiber officinales
Rose) on lindane-induced oxidative stress in rats,” Phytotherapy
Research, vol. 22, no. 7, pp. 902–906, 2008.
[8] R. S. Ahmed, S. G. Suke, V. Seth, A. Chakraborti, A. K. Tripathi, and
B.D. Banerjee, “Protective effects of dietaryginger (Zingiber officinales
Rose) on lindane-induced oxidative stress in rats,” Phytotherapy
Research, vol. 22, no. 7, pp. 902–906, 2008.
[9] A. S. Naura and R. Sharma, “Toxic effects of hexaammine cobalt (III)
chloride on liver and kidney in mice: implication of oxidative stress,”
Drug and Chemical Toxicology, vol. 32, no. 3, pp. 293–299, 2009.
[10] J M. Germain, E. B. Affar, D. D’Amours, V. M. Dixit, G. S. Salvesen,
and G. G. Poirier, “Cleavage of automodified poly(ADP-ribose)
polymerase during apoptosis. Evidence for involvement of caspase-7,”
The Journal of Biological Chemistry, vol. 274, no. 40, pp. 28379–28384,
1999.
[11] S. Shimizu, Y. Eguchi, W. Kamiike et al., “Bcl-2 blocks loss of
mitochondrial membrane potential while ICE inhibitors act at a different
step during inhibition of death induced by respiratory chain inhibitors,”
Oncogene, vol. 13, no. 1, pp. 21–29, 1996.
[12] J. Yang, X. Liu, K. Bhalla et al., “Prevention of apoptosis by Bcl2:
release of cytochrome c frommitochondria blocked,” Science, vol. 275,
no. 5303, pp. 1129–1132, 1997.
[13] Y. Hu, M. A. Benedict, D. Wu, N. Inohara, and G. Nunez, “Bcl-XL
interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9
activation,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 95, no. 8, pp. 4386–4391, 1998.